Polygonatum Cepa
NDC 48951-8310, Polygonatum Cepa, gel, from Uriel Pharmacy Inc..
- Product NDC
- 48951-8310
- Status
- Listed
- Labeler
- Uriel Pharmacy Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/48951-8310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONION2 [hp_X]/g
- ECHINACEA ANGUSTIFOLIA2 [hp_X]/g
- HIRUDIN4 [hp_X]/g
- POLYGONATUM CYRTONEMA ROOT4 [hp_X]/g
- VESPA CRABRO6 [hp_X]/g
- GOLD8 [hp_X]/g
- BOS TAURUS CARTILAGE8 [hp_X]/g
- COPPER8 [hp_X]/g
- SUS SCROFA SKIN8 [hp_X]/g
- BOS TAURUS PLACENTA8 [hp_X]/g
- SILICON DIOXIDE8 [hp_X]/g
- THUJA OCCIDENTALIS WHOLE8 [hp_X]/g
- SILVER12 [hp_X]/g
- BARIUM CITRATE12 [hp_X]/g
- GRAPHITE17 [hp_X]/g
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Inhibit Ovum Fertilization [PE]; Non-Standardized Animal Skin Allergenic Extract [EPC]; Non-Standardized Food Allergenic Extract [EPC]; Standardized Chemical Allergen [EPC]; Vegetable Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 48951-8310-5 | 48951831005 | 60 g in 1 TUBE (48951-8310-5) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 48951-8310 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/48951-8310 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 48951-8310. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.